Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,890Revenue (TTM) $M1,587Net Margin (%)15.5Altman Z-Score4.4
Enterprise Value $M3,990EPS (TTM) $4.2Operating Margin %18.3Piotroski F-Score7
P/E(ttm)16.8Beneish M-Score-2.7Pre-tax Margin (%)18.0Higher ROA y-yY
Price/Book4.610-y EBITDA Growth Rate %-1.1Quick Ratio1.7Cash flow > EarningsY
Price/Sales2.75-y EBITDA Growth Rate %12.0Current Ratio1.7Lower Leverage y-yN
Price/Free Cash Flow18.1y-y EBITDA Growth Rate %31.5ROA % (ttm)14.4Higher Current Ratio y-yY
Dividend Yield %--PEG1.3ROE % (ttm)27.5Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M55.1ROIC % (ttm)28.1Gross Margin Increase y-yY

Gurus Latest Trades with ICLR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ICLRRon Baron 2016-03-31 Reduce-0.05%$66.04 - $77.7
($70.12)
$ 70.01-0%Reduce -14.04%931,953
ICLRRon Baron 2015-12-31 Reduce-0.02%$63.87 - $78.14
($71.52)
$ 70.01-2%Reduce -4.79%1,084,201
ICLRRon Baron 2015-06-30 Reduce-0.09%$63.29 - $71.66
($67.51)
$ 70.014%Reduce -22.48%1,138,759
ICLRFirst Eagle Investment 2014-06-30 Sold Out -0.0015%$37.92 - $48.97
($43.22)
$ 70.0162%Sold Out0
ICLRRon Baron 2013-09-30 Add0.05%$36.24 - $40.67
($38.49)
$ 70.0182%Add 25.15%1,280,000
ICLRRon Baron 2013-06-30 Add0.04%$29.2 - $36.22
($32.9)
$ 70.01113%Add 24.31%1,022,800
ICLRMeridian Funds 2013-03-31 Reduce-0.17%$27.25 - $32.91
($29.87)
$ 70.01134%Reduce -33.19%308,000
ICLRRon Baron 2013-03-31 Buy 0.15%$27.25 - $32.91
($29.87)
$ 70.01134%New holding822,800
ICLRMeridian Funds 2012-12-31 Reduce-0.16%$23.46 - $28.54
($26.39)
$ 70.01165%Reduce -28.22%461,000
ICLRMeridian Funds 2012-06-30 Add0.1%$20.51 - $23.23
($21.82)
$ 70.01221%Add 24.87%642,200
ICLRMeridian Funds 2012-03-31 Add0.06%$17.06 - $22.01
($19)
$ 70.01268%Add 25.16%514,300
ICLRFirst Eagle Investment 2011-09-30 Add$16.5 - $25.21
($20.62)
$ 70.01240%Add 36.36%15,000
ICLRMeridian Funds 2011-06-30 Buy 0.24%$21.18 - $25.92
($24.03)
$ 70.01191%New holding351,000
ICLRFirst Eagle Investment 2010-12-31 Add$19.22 - $22.22
($20.61)
$ 70.01240%Add 37.50%11,000
ICLRGeorge Soros 2010-09-30 Sold Out -0.03%$21.7 - $27.69
($24.14)
$ 70.01190%Sold Out0
ICLRFirst Eagle Investment 2010-06-30 Reduce$26.2 - $29.99
($27.9)
$ 70.01151%Reduce -42.86%8,000
ICLRGeorge Soros 2010-03-31 Add$21.61 - $27.27
($24.53)
$ 70.01185%Add 27.15%28,100
ICLRGeorge Soros 2009-12-31 Add0.01%$21.23 - $26.24
($23.21)
$ 70.01202%Add 169.51%22,100
ICLRGeorge Soros 2009-09-30 Buy $20.87 - $24.68
($22.71)
$ 70.01208%New holding8,200
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ICLR is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ICLR: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about ICLR :

Quarterly/Annual Reports about ICLR:

    News about ICLR:

    Articles On GuruFocus.com
    Dynamite Comes in Small Packages: 10 Small Caps to Get Explosive Returns Apr 01 2016 
    Probable Gainers Of A European Market Bounce Back Jan 25 2015 
    Meridian Funds Comments on Icon PLC Dec 17 2014 
    Meridian Contrarian Fund 3Q 2014 Commentary Dec 17 2014 
    Baron Funds Comments on ICON PLC Jun 10 2013 
    Parexcel: Great Growth but a Tough Business Aug 17 2011 
    Weekly Guru Bargains Highlights: SD, CREE, AMLN, ICLR, CVD Nov 07 2010 

    More From Other Websites
    ICON to Acquire Clinical Research Management, Inc. Jun 30 2016
    8:03 am ICON plc to acquire Clinical Research Management; no financial terms disclosed Jun 30 2016
    ICON to Acquire Clinical Research Management, Inc. Jun 30 2016
    ICON Plc :ICLR-US: Earnings Analysis: Q1, 2016 By the Numbers : June 28, 2016 Jun 28 2016
    Healthcare Opportunities in Light of Brexit-Driven Selloff Jun 28 2016
    ICON Plc breached its 50 day moving average in a Bullish Manner : ICLR-US : June 27, 2016 Jun 27 2016
    ICON: DIA Live to Provide a Digital Window into DIA Conference 2016 Jun 23 2016
    ICON: DIA Live to Provide a Digital Window into DIA Conference 2016 Jun 23 2016
    Coverage initiated on ICON plc by Credit Suisse Jun 21 2016
    ICON and Pfizer Extend Ties, Sign New Agreement Jun 15 2016
    New Research from ICON Demonstrates Support for ‘Bring Your Own Device' Approach in Clinical... Jun 15 2016
    New Research from ICON Demonstrates Support for ‘Bring Your Own Device’ Approach in Clinical... Jun 15 2016
    ICON Reveals Service Deal With Pfizer Jun 10 2016
    ICON Announces Service Agreement with Pfizer Jun 10 2016
    ICON Announces Service Agreement with Pfizer Jun 10 2016
    ICON Plc breached its 50 day moving average in a Bullish Manner : ICLR-US : June 1, 2016 Jun 01 2016
    ICON and Pfizer Honoured as Clinical Research Team of the Year at the Clinical and Research... May 16 2016
    ICON and Pfizer Honoured as Clinical Research Team of the Year at the Clinical and Research... May 16 2016
    ETF’s with exposure to ICON Plc : April 28, 2016 Apr 28 2016
    ICON Plc :ICLR-US: Earnings Analysis: Q1, 2016 By the Numbers Apr 27 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)